Kristine Wong

7PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 09, 2026
Phase 1 trial and biomarker analysis of Buparlisib with weekly Cisplatin and Radiotherapy in high risk locally advanced squamous cell cancer of the Head and Neck.

|Oct 09, 2025
Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma.

Glenn J Hanna, Nicole Scarfo, Kee-Young Shin

|Dec 23, 2024
A Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue-Modified Viral HPV DNA.

Eleni M Rettig, Jonathan D Schoenfeld, Julianna Miller

|Dec 03, 2024
Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma.

Glenn J Hanna, L B Oakley, R Shi

|Jun 01, 2023
Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes.

Athanasios Bikas, Sara Ahmadi, Theodora Pappa

|Aug 15, 2022
The new endocrine WHO classification: What does this mean for thyroid cytology?

Kristine S Wong, Justine A Barletta

Pageof 2

Frequent Collaborators

4 joint publications

Glenn J Hanna

4 joint publications

Kartik Sehgal

4 joint publications

Robert I Haddad

3 joint publications

Anne O'Neill